Lifetime Cost-Utility Analyses of Deferasirox in Beta-Thalassaemia Patients with Chronic Iron Overload
figure
posted on 2018-02-27, 15:50 authored by Jonathan Karnon, Keith Tolley, Joao Vieira, David ChandiwanaThe full text can be found at:
https://link.springer.com/article/10.1007/s40261-012-0008-2
